Skip to main content
Top
Published in: Abdominal Radiology 3/2015

01-03-2015

Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer

Authors: D. I. Glazer, M. S. Davenport, S. Khalatbari, R. H. Cohan, J. H. Ellis, E. M. Caoili, E. B. Stein, J. C. Childress, W. R. Masch, J. M. Brown, B. J. Mollard, J. S. Montgomery, G. S. Palapattu, I. R. Francis

Published in: Abdominal Radiology | Issue 3/2015

Login to get access

Abstract

Purpose

To determine whether focal peripheral zone enhancement on routine venous-phase CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer.

Materials and methods

IRB approval was obtained and informed consent waived for this HIPAA-compliant retrospective study. Forty-three patients with higher-grade prostate cancer (≥Gleason 4 + 3) and 96 with histology-confirmed lower-grade (≤Gleason 3 + 4 [n = 47]) or absent (n = 49) prostate cancer imaged with venous-phase CT comprised the study population. CT images were reviewed by ten blinded radiologists (5 attendings, 5 residents) who scored peripheral zone enhancement on a scale of 1 (benign) to 5 (malignant). Mass-like peripheral zone enhancement was considered malignant. Likelihood ratios (LR) and specificities were calculated. Multivariate conditional logistic regression analyses were conducted.

Results

Scores of “5” were strongly predictive of higher-grade prostate cancer (pooled LR+ 9.6 [95% CI 5.8–15.8]) with rare false positives (pooled specificity: 0.98 [942/960, 95% CI 0.98–0.99]; all 10 readers had specificity ≥95%). Attending scores of “5” were more predictive than resident scores of “5” (LR+: 14.7 [95% CI 5.8–37.2] vs. 7.6 [95% CI 4.2–13.7]) with similar specificity (0.99 [475/480, 95% CI 0.98–1.00] vs. 0.97 [467/480, 95% CI 0.96–0.99]). Significant predictors of an assigned score of “5” included presence of a peripheral zone mass (p < 0.0001), larger size (p < 0.0001), and less reader experience (p = 0.0008). Significant predictors of higher-grade prostate cancer included presence of a peripheral zone mass (p = 0.0002) and larger size (p < 0.0001).

Conclusion

Focal mass-like peripheral zone enhancement on routine venous-phase CT is specific and predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer.
Literature
1.
go back to reference Engeler CE, Wasserman NF, Zhang G (1992) Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives. Urology 40:346–350CrossRefPubMed Engeler CE, Wasserman NF, Zhang G (1992) Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives. Urology 40:346–350CrossRefPubMed
2.
go back to reference Chang P, Friedland GW (1990) The role of imaging in screening for prostate cancer. A decision analysis perspective. Invest Radiol 25:591–595CrossRefPubMed Chang P, Friedland GW (1990) The role of imaging in screening for prostate cancer. A decision analysis perspective. Invest Radiol 25:591–595CrossRefPubMed
3.
go back to reference Purohit RS, Shinohara K, Meng MV, et al. (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279–293CrossRefPubMed Purohit RS, Shinohara K, Meng MV, et al. (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279–293CrossRefPubMed
4.
go back to reference Hricak H, Choyke PL, Eberhardt SC, et al. (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53CrossRefPubMed Hricak H, Choyke PL, Eberhardt SC, et al. (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53CrossRefPubMed
5.
go back to reference O’Dowd GJ, Veltri RW, Orozco R, et al. (1997) Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J Urol 158:687–698CrossRefPubMed O’Dowd GJ, Veltri RW, Orozco R, et al. (1997) Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J Urol 158:687–698CrossRefPubMed
6.
go back to reference Platt JF, Bree RL, Schwab RE (1987) The accuracy of CT in the staging of carcinoma of the prostate. AJR Am J Roentgenol 149:315–318CrossRefPubMed Platt JF, Bree RL, Schwab RE (1987) The accuracy of CT in the staging of carcinoma of the prostate. AJR Am J Roentgenol 149:315–318CrossRefPubMed
8.
go back to reference Turkbey B, Pinto PA, Mani H, et al. (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255:89–99CrossRefPubMedCentralPubMed Turkbey B, Pinto PA, Mani H, et al. (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255:89–99CrossRefPubMedCentralPubMed
9.
go back to reference Hoeks CM, Barentsz JO, Hambrock T, et al. (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66CrossRefPubMed Hoeks CM, Barentsz JO, Hambrock T, et al. (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66CrossRefPubMed
10.
go back to reference Rosenkrantz AB, Sabach A, Babb JS, et al. (2013) Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR Am J Roentgenol 201:W471–W478CrossRefPubMed Rosenkrantz AB, Sabach A, Babb JS, et al. (2013) Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR Am J Roentgenol 201:W471–W478CrossRefPubMed
11.
go back to reference Hoeks CM, Hambrock T, Yakar D, et al. (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric imaging. Radiology 266:207–217CrossRefPubMed Hoeks CM, Hambrock T, Yakar D, et al. (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric imaging. Radiology 266:207–217CrossRefPubMed
12.
go back to reference Mikuz G (2007) Clinical pathology of urological tumours, 1st edn. Boca Raton: CRC PressCrossRef Mikuz G (2007) Clinical pathology of urological tumours, 1st edn. Boca Raton: CRC PressCrossRef
13.
go back to reference Stark JR, Perner S, Stampfer MJ, et al. (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27:3459–3464CrossRefPubMedCentralPubMed Stark JR, Perner S, Stampfer MJ, et al. (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27:3459–3464CrossRefPubMedCentralPubMed
Metadata
Title
Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer
Authors
D. I. Glazer
M. S. Davenport
S. Khalatbari
R. H. Cohan
J. H. Ellis
E. M. Caoili
E. B. Stein
J. C. Childress
W. R. Masch
J. M. Brown
B. J. Mollard
J. S. Montgomery
G. S. Palapattu
I. R. Francis
Publication date
01-03-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0233-7

Other articles of this Issue 3/2015

Abdominal Radiology 3/2015 Go to the issue

Classics in Abdominal Imaging

The cobra head sign

Classics in Abdominal Imaging

The renal artery string-of-pearls sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine